PGNY — Progyny, Inc. Stock Price, Chart & AI Report

Neutral Feb 12, 2026 • 19:46 UTC GlobeNewswire Inc. • Na

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

Progyny, Inc. announced it will report its financial results for Q4 2025 and full year 2025 on February 26, 2026, after market close. The company will host a conference call at 4:45 p.m. ET to discuss results. A live webcast will be available on the company's investor relations website.

PGNY financial results Q4 2025 earnings call women's health family building fertility solutions

Sentiment note

The article is a factual announcement of upcoming earnings results and conference call details. No forward-looking statements, guidance changes, or performance metrics are disclosed that would indicate positive or negative sentiment. It is purely informational regarding the timing and logistics of the earnings announcement.

Positive Dec 2, 2025 • 23:16 UTC The Motley Fool • Josh Kohn-Lindquist

CEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too?

Progyny's CEO Peter Anevski purchased 79,500 shares worth approximately $1.9 million, increasing his direct ownership to 680,251 shares. The purchase signals confidence in the company's performance, which has seen 9% sales growth and near-100% customer retention.

PGNY fertility benefits insider trading stock purchase healthcare services

Sentiment note

Strong financial performance, 60% total return in past year, continued sales growth, high customer retention, and CEO's significant stock purchase indicate positive company outlook

Positive Nov 7, 2025 • 18:02 UTC The Motley Fool • Josh Kohn-Lindquist

Why Progyny Stock Is Soaring Today

Progyny reported strong Q3 earnings with 9% sales growth and 23% adjusted growth, maintaining high client retention and demonstrating resilience after losing Amazon as a customer.

PGNY AMZN fertility women's health benefits management earnings stock performance

Sentiment note

Exceeded analyst expectations, showed 23% adjusted sales growth, maintained near-100% client retention, and has strong financial position with $300M cash and $200M stock buyback

Positive Apr 24, 2025 • 18:49 UTC GlobeNewswire Inc. • N/A

Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report

Progyny, Inc. (PGNY) will report its Q1 2025 financial results on May 8, 2025, and host a conference call to discuss the results.

PGNY Progyny financial results conference call

Sentiment note

The article announces Progyny's upcoming financial results and conference call, which suggests the company is performing well and providing updates to investors.

Positive Feb 28, 2025 • 16:08 UTC The Motley Fool • Jesterai

Progyny Tops EPS Forecast, Eyes Growth

Progyny, a leading fertility benefits provider, reported strong Q4 2024 results, with revenue and adjusted EPS exceeding analyst estimates. However, the company faced setbacks, including the loss of a significant client, which affected its growth projection for 2025. Variability in member engagement remains a concern, and the company's future revenues and treatment utilization rates are less predictable.

PGNY Progyny fertility benefits earnings revenue adjusted EPS client retention member engagement

Sentiment note

Progyny reported strong financial results, with revenue and adjusted EPS exceeding analyst estimates. This indicates the company is performing well and delivering value to its clients and members.

Negative Feb 10, 2025 • 22:41 UTC GlobeNewswire Inc. • N/A

Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm

Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of Progyny, Inc. (PGNY). Shareholders may be entitled to damages and corporate governance reforms.

PGNY Progyny shareholder litigation fiduciary duties self-dealing

Sentiment note

The article indicates that Kuehn Law is investigating potential breaches of fiduciary duties by Progyny's officers and directors, which suggests potential wrongdoing or mismanagement within the company.

Negative Dec 12, 2024 • 03:38 UTC GlobeNewswire Inc. • N/A

Robbins LLP Informs Progyny, Inc. Stockholders that it is Investigating the Officers and Directors of PGNY to Determine if They Breached Fiduciary Duties Owed to Shareholders

Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (PGNY) to determine whether certain officers and directors violated securities laws and breached fiduciary duties to shareholders.

PGNY Progyny fiduciary duties shareholder rights

Sentiment note

The article indicates that Robbins LLP is investigating Progyny's officers and directors for potential breach of fiduciary duties, which suggests potential wrongdoing or mismanagement by the company's leadership.

Negative Nov 13, 2024 • 21:40 UTC The Motley Fool • Josh Kohn-Lindquist

Why Progyny Stock Crashed Today

Progyny, a leading fertility benefits manager, reported Q3 results that missed analysts' expectations, with revenue growth of only 2%. The company's Q4 guidance also disappointed, leading to a 19% drop in its stock price. Despite the slowdown, Progyny remains the leader in its niche, and its offerings are becoming more necessary as infertility rates rise.

PGNY Progyny fertility benefits earnings miss revenue growth stock price

Sentiment note

Progyny's Q3 earnings missed analysts' expectations, and its Q4 guidance was also disappointing, leading to a 19% drop in its stock price. The company's revenue growth has slowed significantly from triple digits in 2020 to barely positive today.

Negative Oct 22, 2024 • 00:12 UTC GlobeNewswire Inc. • N/A

Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman

Fertility benefits provider Progyny (PGNY) is under investigation by Hagens Berman law firm following the unexpected departure of a major client, reportedly Amazon. The firm is looking into whether Progyny's management misled investors about its client retention rates.

PGNY AMZN Progyny Hagens Berman client retention Amazon

Sentiment note

The article suggests that Progyny may have misled investors about its client retention rates, which led to the unexpected departure of a major client. This could have a negative impact on the company's financial performance and reputation.

Negative Oct 10, 2024 • 17:58 UTC GlobeNewswire Inc. • Reed Kathrein

Progyny (PGNY) Crashes After Losing Significant Client - Hagens Berman

Hagens Berman is investigating Progyny, Inc. (NASDAQ: PGNY) after the company lost a significant client, which caused a 33% drop in its stock price. The investigation focuses on potential violations of U.S. securities laws and whether Progyny management knew about customer satisfaction or service quality issues.

PGNY Progyny client loss securities law violations investigation

Sentiment note

Progyny lost a significant client, which caused a substantial drop in its stock price and prompted an investigation into potential securities law violations and management's knowledge of customer satisfaction or service quality issues.

Negative Oct 5, 2024 • 20:23 UTC GlobeNewswire Inc. • Reed Kathrein

Progyny (PGNY) Crashes After Losing Significant Client - Hagens Berman

Hagens Berman is investigating Progyny, Inc. (NASDAQ: PGNY) after the company lost a significant client, which caused a 33% drop in its stock price. The investigation focuses on potential violations of U.S. securities laws and whether Progyny management knew about customer satisfaction or service quality issues.

PGNY Progyny client loss securities law violations investigation

Sentiment note

Progyny lost a significant client, which caused a substantial drop in its stock price and prompted an investigation into potential securities law violations and management's knowledge of customer satisfaction or service quality issues.

Negative Sep 20, 2024 • 18:47 UTC Benzinga • Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Progyny, Inc. (PGNY) on Behalf of Investors

Progyny, Inc. disclosed the loss of a significant client representing 12% of its revenue, causing a 32.7% drop in its stock price. The Law Offices of Frank R. Cruz is investigating the company for possible violations of federal securities laws.

PGNY Progyny securities law stock price drop

Sentiment note

Progyny disclosed the loss of a significant client, which led to a significant drop in its stock price, potentially indicating financial and operational challenges for the company.